Aptus Endosystems secures $15M in financing round
Aptus Endosystems has completed $15 million in Series AA financing, which will be used advance the development of its Aptus EndoStapling system, part of the Aptus Endovascular abdominal aortic aneurysm (AAA) repair system, throughout Europe and the U.S.

According to the Sunnyvale, Calif.-based company, U.S. Venture Partners and Longitude Capital led the current round of funding. The financing was also based on obtaining a CE mark for the company's Aptus Endovascular AAA Repair system and the completion of the STAPLE-2 U.S. clinical trial, the company said.

The Aptus Endovascular AAA Repair system features an endograft and EndoStapling system that are used as an alternative to surgical repair and separate aneurysm exclusions and endograft fixation. Additionally, the company said that it is looking into the development of a thoracic aortic aneurysm (TAA) repair system.

Around the web

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Philips introduced a new CT system at ECR aimed at the rapidly growing cardiac CT market, incorporating numerous AI features to optimize workflow and image quality.

Trimed Popup
Trimed Popup